866-997-4948(US-Canada Toll Free)

MolecularMD, Corp. - Product Pipeline Analysis

Published By :

GlobalData

Published Date : May 2012

Category :

Surgical Equipment

No. of Pages : 22 Pages


MolecularMD, Corp. (MolecularMD) is a medical device company, engaged in providing molecular diagnostic products and services designed to help in handling the significant challenges faced by the developers of targeted cancer treatments. The company specializes in the development and commercialization of pharmacogenomic diagnostic tests. It develops assays to address the healthcare considerations of doctors, patients and payors. The company has strong expertise in chronic Myelogenous Leukemia (CML) research and management. The company is both CLIA approved and CAP accredited.

This report is a source for data, analysis and actionable intelligence on the MolecularMD, Corp. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3
MolecularMD, Corp. - Business Description 4
Key Facts 5
MolecularMD, Corp. - Major Products and Services 6
MolecularMD, Corp. Pipeline Products by Equipment Type 7
MolecularMD, Corp. Pipeline Products by Development Stage 9
MolecularMD, Corp. Pipeline Products by Therapy Area 11
c-KIT Cancer Gene Mutation Assay 13
c-KIT Cancer Gene Mutation Assay Product Status 13
c-KIT Cancer Gene Mutation Assay Product Description 13
Diagnostic Assay - Melanoma 14
Diagnostic Assay - Melanoma Product Status 14
Diagnostic Assay - Melanoma Product Description 14
EGFR T790M Cancer Gene Mutation Assay 15
EGFR T790M Cancer Gene Mutation Assay Product Status 15
EGFR T790M Cancer Gene Mutation Assay Product Description 15
T315I Diagnostic Test 16
T315I Diagnostic Test Product Status 16
T315I Diagnostic Test Product Description 16
MolecularMD, Corp. - Key Competitors 17
MolecularMD, Corp. - Key Employees 18
MolecularMD, Corp. - Key Employee Biographies 19
MolecularMD, Corp. - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
MolecularMD, Corp., Recent Developments 21
Dec 09, 2011: MolecularMD Announces Issuance Of Patent Covering Methods For Therapeutic Resistance Monitoring In Lung Cancer Patients 21
Dec 09, 2011: MolecularMD Receives Patent Covering Methods For Therapeutic Resistance Monitoring In Lung Cancer Patients 21

Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Table


MolecularMD, Corp., Key Facts 1
MolecularMD, Corp. Key Pipeline Products by Equipment Type 1
MolecularMD, Corp. Key Pipeline Products by Therapy Area 1
MolecularMD, Corp. Key Pipeline Products by Development Stage 1
MolecularMD, Corp., Key Facts 5
MolecularMD, Corp., Major Products and Services 6
MolecularMD, Corp. Number of Pipeline Products by Equipment Type 7
MolecularMD, Corp. Pipeline Products by Equipment Type 8
MolecularMD, Corp. Number of Pipeline Products by Development Stage 9
MolecularMD, Corp. Pipeline Products by Development Stage 10
MolecularMD, Corp. Number of Pipeline Products by Therapy Area 11
MolecularMD, Corp. Pipeline Products by Therapy Area 12
c-KIT Cancer Gene Mutation Assay - Product Status 13
c-KIT Cancer Gene Mutation Assay - Product Description 13
Diagnostic Assay - Melanoma - Product Status 14
Diagnostic Assay - Melanoma - Product Description 14
EGFR T790M Cancer Gene Mutation Assay - Product Status 15
EGFR T790M Cancer Gene Mutation Assay - Product Description 15
T315I Diagnostic Test - Product Status 16
T315I Diagnostic Test - Product Description 16
MolecularMD, Corp., Key Employees 18
MolecularMD, Corp., Key Employee Biographies 19

List of Chart


MolecularMD, Corp. Key Pipeline Products by Equipment Type 1
MolecularMD, Corp. Pipeline Products by Equipment Type 7
MolecularMD, Corp. Pipeline Products by Development Stage 9
MolecularMD, Corp. Pipeline Products by Therapy Area 11

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *